Efficacy Study of RX-10100 to Treat Erectile Dysfunction (ED)
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of this Phase IIa trial is to determine the effective doses and
treatment period for an upcoming RX-10100 Phase IIb trial in subjects with erectile
dysfunction (ED). The secondary objectives of this trial are to evaluate the safety and the
quality of life in subjects with ED receiving RX-10100 treatment.